Community Practice Connections™: MRD Assessment as a Cornerstone to Clinical Decision-Making in Hematologic Malignancies: Techniques, Utilization, and Best Practices to Optimize Patient Outcomes
Community Practice Connections™: MRD Assessment as a Cornerstone to Clinical Decision-Making in Hematologic Malignancies: Techniques, Utilization, and Best Practices to Optimize Patient Outcomes is organized by Physicians' Education Resource, LLC (PER).
Release Date: February 28, 2023
Expiration Date: February 28, 2024
Description:
The incorporation of measurable residual disease (MRD) assessment in the treatment algorithm for patients with hematologic malignancies has been established for some diseases, such as acute lymphoblastic leukemia, and it is emerging in other diseases. The need to evaluate MRD also triggers other important decisions, such as selecting an assay, determining sensitivity levels, and assessing the impact of other factors, such as high-risk disease characteristics. It is important for clinicians to effectively evaluate and manage MRD in order to maximize the benefits of therapy.
This Community Practice Connection™ program provides an in-depth review of some of the key highlights from MRD Assessment as a Cornerstone to Clinical Decision-Making in Hematologic Malignancies: Techniques, Utilization, and Best Practices to Optimize Patient Outcomes, held in December 2022. This unique and engaging multimedia activity is ideal for the community-based clinician and focuses on the practical aspects of managing patients with hematologic malignancies, putting recent clinical trial data into clinical context. The program is designed for those who did not attend the live meeting and to help reinforce learnings for those who did.
Learning Objectives:
Upon successful completion of this activity, you should be better prepared to:
• Explain best practices in the assessment of MRD across hematologic malignancies, including the techniques and platforms
• Determine guideline recommendations and expert consensus to inform the use of MRD monitoring in managing hematologic malignancies
• Analyze the role of MRD assessment when planning treatment across the continuum of care for hematologic malignancies
• Formulate plans to integrate emerging data, sampling techniques, MRD assessment, and clinical trial data into the management of patients with hematologic malignancies